Hubert Chen
Keine laufenden Positionen mehr
Vermögen: 69 026 $ am 30.04.2024
Karriereverlauf von Hubert Chen
Ehemalige bekannte Positionen von Hubert Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FORTE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.06.2022 | 15.03.2024 |
| Präsident | 07.06.2022 | 15.03.2024 | |
| METACRINE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2018 | 31.12.2021 |
| PFENEX INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2014 | 02.09.2018 |
| AILERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2012 | 01.10.2014 |
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 17.03.2010 | 01.01.2012 |
| The University of California, San Francisco | Corporate Officer/Principal | 01.01.2002 | 01.01.2012 |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services The J. David Gladstone Institutes operates as an independent state-of-the-art biomedical research institution. The company was founded in 1979 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.01.2009 |
| Corporate Officer/Principal | - | - |
Ausbildung von Hubert Chen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 12 |
Operativ
| Corporate Officer/Principal | 6 |
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| FORTE BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services The J. David Gladstone Institutes operates as an independent state-of-the-art biomedical research institution. The company was founded in 1979 and is headquartered in San Francisco, CA. | Commercial Services |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Hubert Chen
- Erfahrung
